INTRODUCTION
Dermatoporosis is a term first coined by Kaya and Saurat in 2007, describing progressive skin thinning, extracellular matrix (ECM) degradation, vascular fragility with resultant purpura, and general vulnerability of the skin.1 The condition likely affects the vast majority of the population, but it usually manifests in the older age group, typically those over 65 years old. It is underrecognized and may be regarded as the equivalent of "osteoporosis of the skin", often starting decades earlier than the manifestation seen in older age groups.
Traditionally, the pathogenesis was regarded as one of ECM deficiency, particularly related to glycosaminoglycans (hyaluronic acid in particular), with decreased cellular turnover.2 More recently, DP has been recognized as associated with a more extensive global ECM degradation, fibroblast senescence, and macrophage dysfunction.3 This ECM degradation affects the structural support of the vasculature, making it more vulnerable to damage and injury.3
A recent clinical trial evaluating regenerative peptides with ECM remodulating activity and marked clinical improvement has demonstrated that the earliest measurable changes appear to be observed in structural changes to the dermoepidermal junction (DEJ), which precede widespread regenerative changes in the ECM and dermis.4 This suggests that the DEJ, rather than being a passive basement membrane providing structural support, may well signal and initiate the regenerative changes seen with DP reversal.
The Dermoepidermal Junction
Examining Structure and Function
The DEJ has long been recognized as a structural anchoring membrane fixing basal keratinocytes to the dermal papillary layer. This structural adhesion aids in limiting shear forces from damaging the junction, distributing these shear forces among the undulating rete pegs seen with a healthy DEJ.5 Flattening of the DEJ with aging, effacement of the structure weakens the adhesive forces, decreases the distribution of shearing forces, and subjects the skin to injury and damage, with a predisposition to tears.3
Traditionally, the pathogenesis was regarded as one of ECM deficiency, particularly related to glycosaminoglycans (hyaluronic acid in particular), with decreased cellular turnover.2 More recently, DP has been recognized as associated with a more extensive global ECM degradation, fibroblast senescence, and macrophage dysfunction.3 This ECM degradation affects the structural support of the vasculature, making it more vulnerable to damage and injury.3
A recent clinical trial evaluating regenerative peptides with ECM remodulating activity and marked clinical improvement has demonstrated that the earliest measurable changes appear to be observed in structural changes to the dermoepidermal junction (DEJ), which precede widespread regenerative changes in the ECM and dermis.4 This suggests that the DEJ, rather than being a passive basement membrane providing structural support, may well signal and initiate the regenerative changes seen with DP reversal.
The Dermoepidermal Junction
Examining Structure and Function
The DEJ has long been recognized as a structural anchoring membrane fixing basal keratinocytes to the dermal papillary layer. This structural adhesion aids in limiting shear forces from damaging the junction, distributing these shear forces among the undulating rete pegs seen with a healthy DEJ.5 Flattening of the DEJ with aging, effacement of the structure weakens the adhesive forces, decreases the distribution of shearing forces, and subjects the skin to injury and damage, with a predisposition to tears.3





